We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$625M
Turnover
41.45%
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter
Est. Return
+5.08%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$472M
AUM Growth
+$17.9M
(+3.9%)
Cap. Flow
-$5.7M
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
41.49%
Holding
167
New
7
Increased
37
Reduced
41
Closed
18
Avg Time Held
3.6
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xometry
XMTR
|
+$8.54M |
| 2 |
Pfizer
PFE
|
+$3.01M |
| 3 |
Cisco
CSCO
|
+$2.08M |
| 4 |
Zoetis
ZTS
|
+$2.07M |
| 5 |
Advanced Micro Devices
AMD
|
+$1.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$7.79M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$6.1M |
| 3 |
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
|
+$911K |
| 4 |
Dollar General
DG
|
+$758K |
| 5 |
Apple
AAPL
|
+$689K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.06% |
| 2 | Healthcare | 13.47% |
| 3 | Consumer Staples | 12.2% |
| 4 | Consumer Discretionary | 12.04% |
| 5 | Communication Services | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
BellRing Brands
BRBR
$1.06B
| – | – |
-4,355
| Closed | -$257K | – |
|
152
Cigna
CI
$79.4B
| – | – |
-585
| Closed | -$212K | – |
|
153
Cipher Digital
CIFR
$3.75B
| – | – |
-24,650
| Closed | -$127K | – |
|
154
Medtronic
MDT
$121B
| – | – |
-6,058
| Closed | -$528K | – |
|
155
Medpace
MEDP
$17.1B
| – | – |
-642
| Closed | -$259K | – |
|
156
MasTec
MTZ
$15.4B
| – | – |
-3,495
| Closed | -$326K | – |
|
157
nVent Electric
NVT
$23.2B
| – | – |
-3,287
| Closed | -$248K | – |
|
158
Reliance Steel & Aluminium
RS
$20.9B
| – | – |
-612
| Closed | -$205K | – |
|
|
159
Invesco S&P 500 Equal Weight ETF
RSP
$97.6B
| – | – |
-36,000
| Closed | -$6.1M | – |
|
160
Vanguard FTSE Developed Markets ETF
VEA
$228B
| – | – |
-10,942
| Closed | -$549K | – |
|
161
Vanguard S&P 500 ETF
VOO
$1.03T
| – | – |
-697
| Closed | -$335K | – |
|
162
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| – | – |
-6,781
| Closed | -$283K | – |
|
163
Vanguard High Dividend Yield ETF
VYM
$81.4B
| – | – |
-2,375
| Closed | -$287K | – |
|
Similar funds
TAM
RIP
LWP
FGA
BVC
APM
PIM
PAS
Bellecapital's Q2 2024 Portfolio in Review
As of Q2 2024, Bellecapital held 167 positions worth $472M, up 3.9% from $454M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Bellecapital's Q2 2024 filing shows 7 new, 37 increased, 41 reduced and 18 closed positions. Its largest new stake was Xometry: 543,347 shares worth $6.28M. The largest sale was Coca-Cola, an estimated $7.79M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.
- Bellecapital's largest Q2 2024 buy was Xometry: 543,347 shares worth $6.28M.
- Bellecapital added most to Pfizer in Q2 2024, an estimated $3.01M increase.
- Bellecapital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $7.79M.
- Bellecapital fully exited Invesco S&P 500 Equal Weight ETF in Q2 2024, selling an estimated $6.1M.
- Bellecapital's ten largest holdings make up 41% of its $472M portfolio in Q2 2024.
- Bellecapital opened 7 new positions and closed 18 in Q2 2024.
- Bellecapital's portfolio value rose 3.9% quarter-over-quarter to $472M.
Based on Bellecapital's 13F filing for Q2 2024, filed 19 Jul 2024.